Evidence map›Paper›PMID 32880094›Full record

Trial reportJournal of occupational rehabilitation2021

Effectiveness of a Tailored Work-Related Support Intervention for Patients Diagnosed with Gastrointestinal Cancer: A Multicenter Randomized Controlled Trial.

A C G N M Zaman, K M A J Tytgat, J H G Klinkenbijl, F C den Boer, M A Brink, J C Brinkhuis, D J Bruinvels, L C M Dol, P van Duijvendijk, P H J Hemmer and 13 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of occupational rehabilitation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Non-medical interventions to enhance return to work for people with cancer.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 2 countries.

A C G N M ZamanAmsterdam UMC (Location AMC), Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands. a.c.zaman@amsterdamumc.nl.ORCID 0000-0001-9746-8483
K M A J TytgatAmsterdam UMC (Location AMC), Department of Gastroenterology, University of Amsterdam, Amsterdam, The Netherlands.
J H G KlinkenbijlDepartment of Surgery, Gelre Hospitals, Apeldoorn, The Netherlands.
F C den BoerDepartment of Surgery, Zaans Medical Center, Zaandam, The Netherlands.
M A BrinkDepartment of Gastroenterology, Meander Medical Center, Amersfoort, The Netherlands.
J C BrinkhuisIKA- Ned, Hilversum, The Netherlands.
D J BruinvelsIKA- Ned, Hilversum, The Netherlands.
L C M DolDepartment of Surgery, Northwest Hospital Group, Alkmaar, The Netherlands.
P van DuijvendijkDepartment of Surgery, Gelre Hospitals, Apeldoorn, The Netherlands.
P H J HemmerDepartment of Surgical Oncology, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
B LammeDepartment of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
O J L LoosveldDepartment of Medical Oncology, Amphia Hospital, Breda, The Netherlands.
M M MokDepartment of Surgery, OLVG (Location East), Amsterdam, The Netherlands.
T RejdaTomas Rejda Counselling (Oncological Occupational Physician), Alphen aan den Rijn, The Netherlands.
H RuttenDepartment of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
A SchoorlemmerAmsterdam UMC (Location AMC), Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.
D J SonneveldDepartment of Surgery, Dijklander Hospital, Hoorn, The Netherlands.
L P S StassenDepartment of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
R P VeenstraDepartment of Gastroenterology, Martini Hospital, Groningen, The Netherlands.
A van de VenDepartment of General Surgery, Flevo Hospital, Almere, The Netherlands.
E R VelzingVel.Onc@Work Counselling (Oncological Occupational Physician), Leidschendam, The Netherlands.
M H W Frings-Dresen *Amsterdam UMC (Location AMC), Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
A G E M de Boer *Amsterdam UMC (Location AMC), Coronel Institute of Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLGelre Hospitals · NLNierstichting · NLAlbert Schweitzer Ziekenhuis · NLAmphia Ziekenhuis · NLMaastricht University · NLMartini Ziekenhuis · NLMeander Medisch Centrum · NLNetherlands Center for Occupational Diseases · NLNorthwest Hospital · USOLVG · NLRadboud University Nijmegen · NLReinier de Graaf Hospital · NLUniversity Medical Center Groningen · NLZaans Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose The aim of this research was to study the effectiveness on return to work (RTW) of an early tailored work-related support intervention in patients diagnosed with curative gastrointestinal cancer. Methods A multicenter randomized controlled trial was undertaken, in which patients were assigned randomly to the intervention or the control group (usual care). The intervention encompassed three psychosocial work-related support meetings, starting before treatment. Five self-reported questionnaires were sent over twelve months of follow-up. Primary outcome was days until RTW (fulltime or partial) and secondary outcomes included work status, quality of life, work ability, and work limitations. Descriptive analysis, Kaplan-Meier analysis, relative risk ratio and linear mixed models were applied. Results Participants (N = 88) had a mean age of 55 years; 67% were male and the most common cancer type was colon cancer (66%). Of the participants, 42 were randomized to the intervention group. The median time from sick leave until RTW was 233 days (range 187-279 days) for the control group, versus 190 days (range 139-240 days) for the intervention group (log-rank p = 0.37). The RTW rate at twelve months after baseline was 83.3% for the intervention group and 73.5% for the control group. Work limitations did statistically differ between the groups over time (p = 0.01), but quality of life and work ability did not. Conclusion Patients in the intervention group seem to take fewer days to RTW, albeit not to a statistically significant extent.Trial registration Trial NL4920 (NTR5022) (Dutch Trial Register https://www.trialregister.nl ).

Indexed as

Gastrointestinal NeoplasmsQuality of LifeEmploymentFemaleHumansMaleMiddle AgedReturn to WorkSick LeaveNeoplasmsRandomized controlled trialRehabilitation researchReturn to workVocational rehabilitation

Identifiers

PMID32880094
PMCPMC8172517
OpenAlexW3082193445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.